ResearcherChinese PLA General HospitalActive in the last 2 years
Peizi Liu
Matched on OpenAlex author ID A5060883042. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2025: 1 paper · 2026: 1 paper
Papers 2
- Metabolic syndrome worsens perioperative and oncological outcomes in patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter propensit… Co-author DOI 10.1016/j.hbpd.2026.06.001↗
- New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter study. Co-author DOI 10.1016/j.hbpd.2025.04.008↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiuping Zhang · 2 shared papers, 2025–2026 · strength 0.48
- Paper Metabolic syndrome worsens perioperative and oncological outcomes in patients with pancreatic ductal adenocarcinoma aft… DOI 10.1016/j.hbpd.2026.06.001↗
- Paper New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicente… DOI 10.1016/j.hbpd.2025.04.008↗
- Zhiming Zhao · 2 shared papers, 2025–2026 · strength 0.48
- Paper Metabolic syndrome worsens perioperative and oncological outcomes in patients with pancreatic ductal adenocarcinoma aft… DOI 10.1016/j.hbpd.2026.06.001↗
- Paper New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicente… DOI 10.1016/j.hbpd.2025.04.008↗
- Rong Liu · 2 shared papers, 2025–2026 · strength 0.48
- Paper Metabolic syndrome worsens perioperative and oncological outcomes in patients with pancreatic ductal adenocarcinoma aft… DOI 10.1016/j.hbpd.2026.06.001↗
- Paper New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicente… DOI 10.1016/j.hbpd.2025.04.008↗
- Kai Liu · 1 shared paper, 2026 · strength 0.25
- Shuai Xu · 1 shared paper, 2025 · strength 0.23
- Xiaodong Tan · 1 shared paper, 2025 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.